Phibro Animal Ownership
| PAHC Stock | USD 21.90 0.09 0.41% |
Shares in Circulation | First Issued 2013-03-31 | Previous Quarter 41 M | Current Value 41 M | Avarage Shares Outstanding 39.6 M | Quarterly Volatility 3.2 M |
Phibro |
Phibro Stock Ownership Analysis
About 99.0% of the company shares are owned by institutional investors. The book value of Phibro Animal was at this time reported as 6.09. The company has Price/Earnings To Growth (PEG) ratio of 1.66. Phibro Animal Health last dividend was issued on the 5th of March 2025. Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey. Phibro Anl operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 1860 people. To find out more about Phibro Animal Health contact Jack Bendheim at 201 329 7300 or learn more at https://www.pahc.com.Phibro Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Phibro Animal is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Phibro Animal Health backward and forwards among themselves. Phibro Animal's institutional investor refers to the entity that pools money to purchase Phibro Animal's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Parkwood Llc | 2024-12-31 | 481.5 K | Dana Investment Advisors Inc | 2024-12-31 | 409.3 K | Castleknight Management Lp | 2024-12-31 | 389.4 K | Aqr Capital Management Llc | 2024-12-31 | 327.4 K | Arrowstreet Capital Limited Partnership | 2024-12-31 | 322.1 K | Jacobs Levy Equity Management, Inc. | 2024-12-31 | 301.2 K | Charles Schwab Investment Management Inc | 2024-12-31 | 290.7 K | Bank Of New York Mellon Corp | 2024-12-31 | 272.6 K | Northern Trust Corp | 2024-12-31 | 245.1 K | Blackrock Inc | 2024-12-31 | 3.8 M | Vanguard Group Inc | 2024-12-31 | 1.5 M |
Phibro Animal Health Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Phibro Animal insiders, such as employees or executives, is commonly permitted as long as it does not rely on Phibro Animal's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Phibro Animal insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Glenn David over a month ago Acquisition by Glenn David of 30000 shares of Phibro Animal subject to Rule 16b-3 | ||
Corcoran E Thomas over six months ago Acquisition by Corcoran E Thomas of 5000 shares of Phibro Animal at 20.02 subject to Rule 16b-3 | ||
Daniel Bendheim over six months ago Disposition of 2500 shares by Daniel Bendheim of Phibro Animal at 11.83 subject to Rule 16b-3 | ||
Larry Miller over a year ago Acquisition by Larry Miller of 300000 shares of Phibro Animal subject to Rule 16b-3 |
Phibro Animal Outstanding Bonds
Phibro Animal issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Phibro Animal Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Phibro bonds can be classified according to their maturity, which is the date when Phibro Animal Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Phibro Animal Corporate Filings
F4 | 26th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 14th of February 2025 Other Reports | ViewVerify | |
10Q | 5th of February 2025 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 4th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phibro Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phibro Animal. If investors know Phibro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phibro Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.621 | Dividend Share 0.48 | Revenue Per Share | Quarterly Revenue Growth 0.237 | Return On Assets |
The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phibro Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Phibro Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phibro Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.